Wordt geladen...
FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
FGFR3 is a prognostic and predictive marker and is a validated therapeutic target in urothelial bladder cancer. Its utility as a marker and target in the context of immunotherapy is incompletely understood. We review the role of FGFR3 in bladder cancer and discuss preclinical and clinical clues of i...
Bewaard in:
| Gepubliceerd in: | Front Immunol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7674585/ https://ncbi.nlm.nih.gov/pubmed/33224141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.575258 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|